Vietnam is aiming to attract overseas investment to encourage domestic drug development through the amended 2016 Law on ...
Clinical operations teams can expect a high return on investments in AI in the next 5–10 years, according to speakers at ...
IPA has entered a strategic partnership with Ribopro aiming to transform therapeutic antibody discovery and development.
Last month, the NICE endorsed Casgevy for use in the NHS under a managed access scheme to treat sickle cell disease.
The FDA has granted fast track designation to Pyxis oncology’s PYX-201 for the treatment of adults with R/M HNSCC.
Eli Lilly has announced plans to expand its domestic medicine production in the US with four new pharmaceutical manufacturing ...
Pfizer has ended the global commercialisation of its haemophilia B (factor IX deficiency) gene therapy Beqvez, citing soft demand for gene therapies among haemophilia patients and physicians.
The surge in demand for radiopharmaecuticals, the potential affect of Trump's tariffs on the clinical trials space, ensuring ...
The Phase III trial met the primary and secondary endpoints of reducing tics in children and adult patients with Tourette ...